Table 4.
Method: 95.0% LSD | |||
---|---|---|---|
Pathology | Count | Mean | Homogeneous groups |
Healthy donors | 65 | −1.586 | C |
Distant mucosa in OSCC patients | 30 | −0.444399 | B |
OSCC | 29 | 2.66856 | A |
HGSIL | 6 | 2.71892 | A |
Contrast | Sig. | Difference | ± limits |
OSCC–HGSIL | −0.0503633 | 0.983538 | |
OSCC–distant mucosa in OSCC patients | * | 3.11296 | 0.571081 |
OSCC–healthy donors | * | 4.25456 | 0.489711 |
HGSIL–distant mucosa in OSCC patients | * | 3.16332 | 0.980724 |
HGSIL–healthy donors | * | 4.30492 | 0.935683 |
Distant mucosa in OSCC patients–healthy donors | * | 1.1416 | 0.484034 |
*Statistically significant difference